Find a specific notice:
Notice Type
Departmental
Notice Title

Consent to the Distribution of New Medicines

Publication Date
14 Nov 2019

Tags

Medicines Act Consent to the distribution of new medicines Health

Notice Number

2019-go5185
Title
View PDF
File Type and Size
PDF (34 KB)

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

Product:

Kombiglyze XR

Active Ingredients:

Metformin hydrochloride 500mg

Saxagliptin 5mg

Dosage Form:

Modified release tablet

New Zealand Sponsor:

AstraZeneca Limited

Manufacturer:

AstraZeneca Pharmaceuticals LP, Indiana, United States of America

 

 

Product:

Kombiglyze XR

Active Ingredients:

Metformin hydrochloride 1000mg

Saxagliptin 2.5mg

Dosage Form:

Modified release tablet

New Zealand Sponsor:

AstraZeneca Limited

Manufacturer:

AstraZeneca Pharmaceuticals LP, Indiana, United States of America

 

 

Product:

Kombiglyze XR

Active Ingredients:

Metformin hydrochloride 1000mg

Saxagliptin 5mg

Dosage Form:

Modified release tablet

New Zealand Sponsor:

AstraZeneca Limited

Manufacturer:

AstraZeneca Pharmaceuticals LP, Indiana, United States of America

Dated this 8th day of November 2019.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).